{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T08:42:00Z","timestamp":1768034520334,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Clinical Research Center for Gynecological Oncology","award":["2015BAI13B05"],"award-info":[{"award-number":["2015BAI13B05"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81572554"],"award-info":[{"award-number":["81572554"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81502245"],"award-info":[{"award-number":["81502245"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["ZR2014HQ016"],"award-info":[{"award-number":["ZR2014HQ016"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["2015ZRE27404"],"award-info":[{"award-number":["2015ZRE27404"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.yexcr.2017.12.029","type":"journal-article","created":{"date-parts":[[2018,1,2]],"date-time":"2018-01-02T08:11:34Z","timestamp":1514880694000},"page":"160-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["SUSD2 promotes cancer metastasis and confers cisplatin resistance in high grade serous ovarian cancer"],"prefix":"10.1016","volume":"363","author":[{"given":"Ying","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunying","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengjuan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunping","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinuo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beihua","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2017.12.029_bib1","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0140-6736(09)61338-6","article-title":"Ovarian cancer","volume":"374","author":"Hennessy","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.yexcr.2017.12.029_bib2","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.6004\/jnccn.2016.0122","article-title":"Ovarian cancer, version 1.2016, NCCN clinical practice guidelines in oncology","volume":"14","author":"Morgan","year":"2016","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.yexcr.2017.12.029_bib3","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1158\/0008-5472.CAN-11-3911","article-title":"The changing view of high-grade serous ovarian cancer","volume":"72","author":"Berns","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2017.12.029_bib4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.yexcr.2017.12.029_bib5","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10354-014-0323-8","article-title":"Epithelial ovarian cancer - more data, more questions?","volume":"164","author":"Aust","year":"2014","journal-title":"Wien. Med. Wochenschr."},{"key":"10.1016\/j.yexcr.2017.12.029_bib6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nrc1611","article-title":"Ovarian cancer metastasis: integrating insights from disparate model organisms","volume":"5","author":"Naora","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexcr.2017.12.029_bib7","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","article-title":"Molecular mechanisms of epithelial-mesenchymal transition","volume":"15","author":"Lamouille","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.yexcr.2017.12.029_bib8","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.2174\/138945012803530044","article-title":"Targeting pathways contributing to epithelial-mesenchymal transition (EMT) in epithelial ovarian cancer","volume":"13","author":"Huang","year":"2012","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.yexcr.2017.12.029_bib9","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1002\/dvdy.21658","article-title":"Epithelial-mesenchymal transition (EMT) is not sufficient for spontaneous murine breast cancer metastasis","volume":"237","author":"Lou","year":"2008","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.yexcr.2017.12.029_bib10","doi-asserted-by":"crossref","first-page":"149362","DOI":"10.1155\/2010\/149362","article-title":"A current review of targeted therapeutics for ovarian cancer","volume":"2010","author":"Campos","year":"2010","journal-title":"J. Oncol."},{"key":"10.1016\/j.yexcr.2017.12.029_bib11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nrclinonc.2010.37","article-title":"Chemotherapy: current drugs still have potential in advanced ovarian cancer","volume":"7","author":"Hogberg","year":"2010","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.yexcr.2017.12.029_bib12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13048-014-0095-1","article-title":"Notch signaling in serous ovarian cancer","volume":"7","author":"Groeneweg","year":"2014","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.yexcr.2017.12.029_bib13","doi-asserted-by":"crossref","first-page":"6312","DOI":"10.1158\/0008-5472.CAN-05-3610","article-title":"Notch3 gene amplification in ovarian cancer","volume":"66","author":"Park","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2017.12.029_bib14","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1158\/0008-5472.CAN-13-2066","article-title":"Notch3 pathway alterations in ovarian cancer","volume":"74","author":"Hu","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2017.12.029_bib15","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ygyno.2013.03.019","article-title":"Notch3 induces epithelial-mesenchymal transition and attenuates carboplatin-induced apoptosis in ovarian cancer cells","volume":"130","author":"Gupta","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.yexcr.2017.12.029_bib16","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/j.1349-7006.2007.00466.x","article-title":"Isolation of a novel mouse gene, mSVS-1\/SUSD2, reversing tumorigenic phenotypes of cancer cells in vitro","volume":"98","author":"Sugahara","year":"2007","journal-title":"Cancer Sci."},{"key":"10.1016\/j.yexcr.2017.12.029_bib17","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1349-7006.2007.00467.x","article-title":"von Willebrand factor type D domain mutant of SVS-1\/SUSD2, vWD(m), induces apoptosis in HeLa cells","volume":"98","author":"Sugahara","year":"2007","journal-title":"Cancer Sci."},{"key":"10.1016\/j.yexcr.2017.12.029_bib18","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.3892\/ol.2015.3737","article-title":"Reduced expression of sushi domain containing 2 is associated with progression of non-small cell lung cancer","volume":"10","author":"Cai","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.yexcr.2017.12.029_bib19","doi-asserted-by":"crossref","first-page":"9919","DOI":"10.1007\/s13277-015-4734-y","article-title":"SUSD2 is frequently downregulated and functions as a tumor suppressor in RCC and lung cancer","volume":"37","author":"Cheng","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.yexcr.2017.12.029_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12935-016-0286-5","article-title":"Decreased expression of Sushi Domain Containing 2 correlates to progressive features in patients with hepatocellular carcinoma","volume":"16","author":"Liu","year":"2016","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.yexcr.2017.12.029_bib21","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1158\/1541-7786.MCR-12-0501-T","article-title":"Multiple functions of sushi domain containing 2 (SUSD2) in breast tumorigenesis","volume":"11","author":"Watson","year":"2013","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.yexcr.2017.12.029_bib22","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/jcp.24802","article-title":"Epithelial-to-mesenchymal transition induced by TGF-beta1 is mediated by AP1-dependent EpCAM expression in MCF-7 cells","volume":"230","author":"Gao","year":"2015","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.yexcr.2017.12.029_bib23","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1017\/S1478951515000127","article-title":"A systematic review of ovarian cancer and fear of recurrence","volume":"13","author":"Ozga","year":"2015","journal-title":"Palliat. Support Care"},{"key":"10.1016\/j.yexcr.2017.12.029_bib24","first-page":"290","article-title":"Is there a current change of maintenance treatment in ovarian cancer? An updated review of the literature","volume":"21","author":"Kilic Sakarya","year":"2016","journal-title":"J. BUON"},{"key":"10.1016\/j.yexcr.2017.12.029_bib25","doi-asserted-by":"crossref","first-page":"82741","DOI":"10.18632\/oncotarget.12633","article-title":"Is ovarian cancer a targetable disease? A systematic review and meta-analysis and genomic data investigation","volume":"7","author":"Staropoli","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.yexcr.2017.12.029_bib26","doi-asserted-by":"crossref","first-page":"e264","DOI":"10.1038\/oncsis.2016.64","article-title":"SUSD2 expression in high-grade serous ovarian cancer correlates with increased patient survival and defective mesothelial clearance","volume":"5","author":"Sheets","year":"2016","journal-title":"Oncogenesis"},{"key":"10.1016\/j.yexcr.2017.12.029_bib27","unstructured":"EpCAM-Regulated Transcription Exerts Influences on Nanomechanical [PMIDU27569206].pdf."},{"key":"10.1016\/j.yexcr.2017.12.029_bib28","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ygyno.2006.03.035","article-title":"Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer","volume":"103","author":"Spizzo","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.yexcr.2017.12.029_bib29","doi-asserted-by":"crossref","first-page":"e102590","DOI":"10.1371\/journal.pone.0102590","article-title":"Knockdown of EpCAM enhances the chemosensitivity of breast cancer cells to 5-fluorouracil by downregulating the antiapoptotic factor Bcl-2","volume":"9","author":"Gao","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2017.12.029_bib30","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12885-016-2252-y","article-title":"Epithelial cell adhesion molecule in human hepatocellular carcinoma cell lines: a target of chemoresistence","volume":"16","author":"Li","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.yexcr.2017.12.029_bib31","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nrclinonc.2011.136","article-title":"Chemotherapy: cisplatin more effective when given less often","volume":"8","author":"Hutchinson","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.yexcr.2017.12.029_bib32","doi-asserted-by":"crossref","first-page":"a008821","DOI":"10.1101\/cshperspect.a008821","article-title":"Autophagy and cancer","volume":"4","author":"Mah","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.yexcr.2017.12.029_bib33","doi-asserted-by":"crossref","first-page":"17163","DOI":"10.1074\/jbc.M114.558288","article-title":"Role of autophagy in cisplatin resistance in ovarian cancer cells","volume":"289","author":"Wang","year":"2014","journal-title":"J. Biol. Chem."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482717306912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482717306912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T00:22:26Z","timestamp":1535156546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482717306912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0014482717306912"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2017.12.029","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SUSD2 promotes cancer metastasis and confers cisplatin resistance in high grade serous ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2017.12.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}